These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22767403)

  • 21. Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion.
    Carvajal K; Zarrinpashneh E; Szarszoi O; Joubert F; Athea Y; Mateo P; Gillet B; Vaulont S; Viollet B; Bigard X; Bertrand L; Ventura-Clapier R; Hoerter JA
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3136-47. PubMed ID: 17337600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart.
    Sambandam N; Lopaschuk GD
    Prog Lipid Res; 2003 May; 42(3):238-56. PubMed ID: 12689619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of 5'-AMP-activated protein kinase activity does not impair recovery of contractile function during reperfusion of ischemic hearts.
    Folmes CD; Wagg CS; Shen M; Clanachan AS; Tian R; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H313-21. PubMed ID: 19429810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMPK: energy sensor and survival mechanism in the ischemic heart.
    Qi D; Young LH
    Trends Endocrinol Metab; 2015 Aug; 26(8):422-9. PubMed ID: 26160707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
    Yin M; van der Horst IC; van Melle JP; Qian C; van Gilst WH; Silljé HH; de Boer RA
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H459-68. PubMed ID: 21572014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy.
    Ye Y; Birnbaum Y; Widen SG; Zhang Z; Zhu S; Bajaj M; Chen H
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):835-848. PubMed ID: 32767170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase.
    Xing Y; Musi N; Fujii N; Zou L; Luptak I; Hirshman MF; Goodyear LJ; Tian R
    J Biol Chem; 2003 Aug; 278(31):28372-7. PubMed ID: 12766162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection.
    Wang Y; Wang X; Jasmin JF; Lau WB; Li R; Yuan Y; Yi W; Chuprun K; Lisanti MP; Koch WJ; Gao E; Ma XL
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):934-42. PubMed ID: 22328772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sevoflurane Preconditioning Confers Delayed Cardioprotection by Upregulating AMP-Activated Protein Kinase Levels to Restore Autophagic Flux in Ischemia-Reperfusion Rat Hearts.
    Hong L; Sun Y; An JZ; Wang C; Qiao SG
    Med Sci Monit; 2020 Jun; 26():e922176. PubMed ID: 32476662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice.
    Bouhidel O; Pons S; Souktani R; Zini R; Berdeaux A; Ghaleh B
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1580-6. PubMed ID: 18689499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway.
    Lu Q; Liu J; Li X; Sun X; Zhang J; Ren D; Tong N; Li J
    Mol Cell Endocrinol; 2020 Feb; 501():110642. PubMed ID: 31759100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of AMP-activated protein kinase in healthy and diseased hearts.
    Dolinsky VW; Dyck JR
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2557-69. PubMed ID: 16844922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
    J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
    Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
    Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
    Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired Myocardial MIF/AMPK Activation Aggravates Myocardial Ischemia Reperfusion Injury in High-Fat Diet-Induced Obesity.
    Meng F; Li D; Song B; Li L
    Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1046-1054. PubMed ID: 30914037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.